An open label study in children to assess the clinical and serological effects along with safety of rituximab for the treatment of systemic lupus erythematosus.
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 06 Oct 2015 New trial record